Sex: males/females (n) | 27/12 | 28/12 |
|
Age (years) | 62.6 (60.07 to 65.13) | 61.3 (58.16 to 64.44) |
|
Body mass index (kg/m2)b | 28.8 (27.55 to 30.05) | 30.2 (28.79 to 31.61) |
|
Exercise: ‘moderate’ to ‘great’/‘hardly any’ to ‘light’ (%) | 40/60 | 45/55 |
|
Stress: ‘moderate’ to ‘great’/‘not stressful’ (%) | 57.5/42.5 | 45/55 |
|
Smoking: yes/no (%) | 2.5/97.5 | 2.5/97.5 |
|
Waist circumference: males (cm)c | 104.0 (100.10 to 107.90) | 105.0 (101.5 to 108.05) |
|
Waist circumference: females (cm)d | 98.6 (93.36 to 103.84) | 102.5 (96.06 to 108.94) |
|
Waist to hip ratio: males (n)e | 0.97 (0.95 to 0.99) | 0.97 (0.95 to 0.99) |
|
Waist to hip ratio: females (n)f | 0.89 (0.85 to 0.93) | 0.89 (0.86 to 0.92) |
|
Participants on hypoglycaemic medication (n) |
Low-dose insulin | 4 | 3 |
Metformin | 19 | 20 |
Gliclazide | 12 | 16 |
Others | 6 | 7 |
|
Participants on hypotensive medication (n) |
ACE inhibitors | 19 | 15 |
Calcium channel blockers | 8 | 10 |
β-blockers | 6 | 7 |
Diuretics | 10 | 4 |
Others | 2 | 4 |